MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 94 filers reported holding MERUS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,074,000 | -10.4% | 300,000 | 0.0% | 1.04% | -19.5% |
| Q2 2023 | $7,899,000 | +43.1% | 300,000 | 0.0% | 1.30% | +20.4% |
| Q1 2023 | $5,520,000 | +18.9% | 300,000 | 0.0% | 1.08% | +31.4% |
| Q4 2022 | $4,641,000 | -22.8% | 300,000 | 0.0% | 0.82% | -54.6% |
| Q3 2022 | $6,009,000 | -11.5% | 300,000 | 0.0% | 1.80% | -37.5% |
| Q2 2022 | $6,792,000 | -14.4% | 300,000 | 0.0% | 2.88% | -9.4% |
| Q1 2022 | $7,932,000 | +10.9% | 300,000 | +33.3% | 3.18% | -5.0% |
| Q4 2021 | $7,155,000 | – | 225,000 | – | 3.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |